相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。First-in-Human Randomized Study to Assess the Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus (RSV) Vaccine Based on Chimpanzee-Adenovirus-155 Viral Vector-Expressing RSV Fusion, Nucleocapsid, and Antitermination Viral Proteins in Healthy Adults
Paola Cicconi et al.
CLINICAL INFECTIOUS DISEASES (2020)
Safety and immunogenicity of novel modified vaccinia Ankara-vectored RSV vaccine: A randomized phase I clinical trial
Nathaly Samy et al.
VACCINE (2020)
Novel genetically-modified chimpanzee adenovirus and MVA-vectored respiratory syncytial virus vaccine safely boosts humoral and cellular immunity in healthy older adults
Christopher A. Green et al.
JOURNAL OF INFECTION (2019)
Respiratory syncytial virus in hematopoietic cell transplant recipients and patients with hematologic malignancies
Fareed Khawaja et al.
HAEMATOLOGICA (2019)
Immunological Lessons from Respiratory Syncytial Virus Vaccine Development
Tracy J. Ruckwardt et al.
IMMUNITY (2019)
Phase 3 Efficacy Trial of Modified Vaccinia Ankara as a Vaccine against Smallpox
Phillip R. Pittman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
T-Cell Responses in Adults During Natural Respiratory Syncytial Virus Infection
D. Roumanes et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Immunogenicity and safety of three consecutive production lots of the non replicating smallpox vaccine MVA: A randomised, double blind, placebo controlled phase III trial
Edgar Turner Overton et al.
PLOS ONE (2018)
An Adjuvanted, Postfusion F Protein-Based Vaccine Did Not Prevent Respiratory Syncytial Virus Illness in Older Adults
Judith Falloon et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults
Louis Fries et al.
IMMUNITY & AGEING (2017)
Advances in RSV vaccine research and development - A global agenda
Deborah Higgins et al.
VACCINE (2016)
Impaired Antibody-mediated Protection and Defective IgA B-Cell Memory in Experimental Infection of Adults with Respiratory Syncytial Virus
Maximillian S. Habibi et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
RSV-specific airway resident memory CD8+T cells and differential disease severity after experimental human infection
Agnieszka Jozwik et al.
NATURE COMMUNICATIONS (2015)
Cardiac Safety of Modified Vaccinia Ankara for Vaccination against Smallpox in a Young, Healthy Study Population
Eva-Maria Zitzmann-Roth et al.
PLOS ONE (2015)
Adults 65 Years Old and Older Have Reduced Numbers of Functional Memory T Cells to Respiratory Syncytial Virus Fusion Protein
Anu Cherukuri et al.
CLINICAL AND VACCINE IMMUNOLOGY (2013)
Viral Shedding and Immune Responses to Respiratory Syncytial Virus Infection in Older Adults
Edward E. Walsh et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
A review of palivizumab and emerging therapies for respiratory syncytial virus
Kristin A. Shadman et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2011)
Viral Load Drives Disease in Humans Experimentally Infected with Respiratory Syncytial Virus
John P. DeVincenzo et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Seasonal Variation of Maternally Derived Respiratory Syncytial Virus Antibodies and Association with Infant Hospitalizations for Respiratory Syncytial Virus
Lone Graff Stensballe et al.
JOURNAL OF PEDIATRICS (2009)
Modified vaccinia Ankara strains with identical coding sequences actually represent complex mixtures of viruses that determine the biological properties of each strain
Mark Suter et al.
VACCINE (2009)
CD8+ T cell responses in bronchoalveolar lavage fluid and peripheral blood mononuclear cells of infants with severe primary respiratory syncytial virus infections
Jojanneke Heidema et al.
JOURNAL OF IMMUNOLOGY (2007)
Respiratory syncytial virus infection in elderly and high-risk adults
AR Falsey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Humoral and mucosal immunity in protection from natural respiratory syncytial virus infection in adults
EE Walsh et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Correlates of immunity to respiratory syncytial virus (RSV) associated-hospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies
PA Piedra et al.
VACCINE (2003)
Mortality associated with influenza and respiratory syncytial virus in the United States
WW Thompson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
分享论文
